The homolog of p53 gene, p63, encodes multiple p63 protein isoforms. TAp63 proteins contain an N-terminal transactivation domain similar to that of p53 and function as tumor suppressors; whereas DNp63 isoforms, which lack the intact N-terminal transactivation domain, are associated with human tumorigenesis. Accumulating evidence demonstrating the important roles of p63 in development and cancer development, the regulation of p63 proteins, however, is not fully understood. In this study, we show that peptidyl-prolyl isomerase Pin1 directly binds to and stabilizes TAp63a and DNp63a via inhibiting the proteasomal degradation mediated by E3 ligase WWP1. We further show that Pin1 specifically interacts with T 538 P which is adjacent to the P 550 PxY 543 motif, and disrupts p63a-WWP1 interaction. In addition, while Pin1 enhances TAp63a-mediated apoptosis, it promotes DNp63a-induced cell proliferation. Furthermore, knockdown of Pin1 in FaDu cells inhibits tumor formation in nude mice, which is rescued by simultaneous knockdown of WWP1 or ectopic expression of DNp63a. promoter that precedes the first exon encoding the full transactivation domain (TAD) on the N-terminus, and a cryptic 3 0 intronic promoter that gives rise to DN isoforms lacking a full TAD. Both TA and DN isotypes can undergo alternative splicing to generate different carboxy-termini (a, b, g), thus giving rise to at least six different p63 isoforms (TAa, TAb, TAg and DNa, DNb, DNg). Each p63 isoform possesses a DNAbinding domain and an oligomerization domain. In addition, p63a contains a full-length C-terminus, which consists of a sterile alpha motif (SAM) for protein-protein interaction and a trans-inhibitory domain (TID), whereas p63b and p63g isoforms have truncated C-termini due to alternative splicing.
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promoter that precedes the first exon encoding the full transactivation domain (TAD) on the N-terminus, and a cryptic 3 0 intronic promoter that gives rise to DN isoforms lacking a full TAD. Both TA and DN isotypes can undergo alternative splicing to generate different carboxy-termini (a, b, g), thus giving rise to at least six different p63 isoforms (TAa, TAb, TAg and DNa, DNb, DNg). Each p63 isoform possesses a DNAbinding domain and an oligomerization domain. In addition, p63a contains a full-length C-terminus, which consists of a sterile alpha motif (SAM) for protein-protein interaction and a trans-inhibitory domain (TID), whereas p63b and p63g isoforms have truncated C-termini due to alternative splicing. 1, 2 The TAp63 isoforms are potent transactivators of a subset of genes, which in part overlap with p53 downstream targets including Bax, Puma, and p21. Consequently, TAp63s can induce both cell cycle arrest and apoptosis. By contrast, DNp63 isoforms can also transactivate a subset of genes involved in a variety of biological activities. Importantly, DNp63a has been shown to repress transcriptional activity of p53 family members, enabling DNp63a to promote cell proliferation and tumorigenesis under certain circumstances. Pin1 is a ubiquitously expressed peptidyl-prolyl isomerase, consisting of an N-terminal WW domain and a C-terminal PPIase domain. The WW domain functions as the specific binding domain for Pin1 substrates and selectively binds to phospho-Ser-Pro (pSP) or phospho-Thr-Pro (pTP) motifs. 3 Point mutations in the WW domain (W34A, Y23A) of Pin1 abolish the protein-protein interaction between Pin1 and its substrates. After binding to its substrates, Pin1 can facilitate the cis-trans isomerization of pSP/pTP peptidyl-prolyl bonds through its PPIase domain, resulting in conformational and functional changes of substrate proteins. 4 It is well documented that Pin1 has important roles in diverse cellular processes, and is overexpressed in diverse human tumors and promotes oncogenesis by modulating numerous proteins involved in tumorigenesis. [5] [6] [7] Although the association between p63 and Pin1 has been previously reported, the underlying mechanism and physiological effects of this physical interaction remain largely unclear. 8 In this study, we demonstrate that Pin1 binds to TAp63a and protects it from proteasomal degradation, leading to increased apoptosis. On the other hand, Pin1 can also bind to DNp63a and inhibits its degradation. Knockdown of Pin1 in FaDu cells lead to a decrease in DNp63a protein levels and an inhibition of cell proliferation. Our study reveals a mechanism enabling Pin1 to modulate specific p63 isoforms to regulate cell survival/proliferation and tumorigenesis.
Results
Pin1 interacts with p63 in vitro and in vivo. Pin1 has been shown to physically interact with p53 and p73. [9] [10] [11] To test if it can bind to p63 proteins, we performed GST-Pin1 pull-down experiment. Our results showed that TAp63a ( Figure 1a ) TAp63g (Figure 1b ) and DNp63 proteins ( Figure 1c) were readily pulled down with GST-Pin1, but not with GST alone.
It was reported that the physical interactions between Pin1 and its substrates is mediated by the WW domain, but not the PPIase domain of Pin1. Point mutations in the WW domain (Y23A or W34A) completely abolish the interaction between Pin1 and its substrates. 4 As shown in Figure 1d , TAp63a bound to the full length or the WW domain of Pin1, but not the PPIase domain, Pin1(W34A), or Pin1(Y23A). In addition, our results of GST-Pin1 pull-down experiment in combination with calf intestine phosphatase and phosphatase inhibitor treatment showed that the interaction between p63 and Pin1 was dependent on p63 phosphorylation (Supplementary Figure S1) .
Next, we further examined whether p63 proteins could physiologically interact with Pin1. As shown in Figure 1e , TAp63a formed a stable complex with Pin1, but not with Pin1(W34A), in transiently transfected H1299 cells. To examine the in vivo interaction between Pin1 and DNp63a, we performed immunoprecipitation using lysate of the head and neck squamous cell carcinoma (HNSCC) cell line FaDu, which expresses high levels of endogenous Pin1 and DNp63a. As shown in Figure 1f , endogenous Pin1 and DNp63a form a stable complex in FaDu cells. H1299 cells transfected with either TAp63a or TAp63g expression plasmid were lysed and subjected to GST pull-down assay with GST alone (lane 2) or GST-Pin1 (lane 3). 10 mg of total protein from the same cell lysates were directly loaded as input controls (lane 1). Immunoblotting analysis (IB) was performed using an antibody specific for p63 (4A4, a-p63; top panels). Comparable amounts of GST and GST-Pin1 fusion proteins were shown by staining the membrane with Coomassie blue R-250 (bottom panels). (c) Pin1 interacts with DNp63 in vitro. Pull-down experiments were performed as described above. 10 mg of total protein from lysate inputs (top panel) and pull-down products (bottom panel) were subjected to IB analysis with a-p63. . (e) Wild-type but not W34A mutant Pin1 can form a stable complex with TAp63a. Lysates from H1299 cells transiently expressing HA-tagged wild-type or W34A mutant Pin1 were subjected to immunoprecipitation (IP) and IB using myc or HA antibody. (f) Endogenous proteins of DNp63a and Pin1 form a stable complex in FaDu cells. 2 mg of FaDu cell lysate was subjected to IP with a-p63 (4A4) or IgG control. The IP products were subjected to IB with a-p63 or a-Pin1
Taken together, our data demonstrate that p63 proteins, including TAp63a, TAp63g, DNp63a, and DNp63g,can interact with Pin1, whereas W34 and Y23 in the WW domain of Pin1 are critical for its interaction with p63 proteins.
Pin1 specifically stabilizes p63a,but not p63c. Since Pin1 was reported to stabilize p73 proteins, 9 we asked if Pin1 is involved in regulating p63 protein stability. To this end, we transiently co-expressed TAp63a and Pin1 in H1299 cells. The results of immunoblotting showed that expression of wild-type Pin1, but not Pin1(W34A), led to increased TAp63a protein levels; as a control of transfection efficiency, GFP protein levels were not affected (Figure 2a ). In addition, we found that transient expression of Pin1, but not Pin1 (W34A), in HEK293 cell line stably overexpressing DNp63a (HEK293:DNp63a), upregulates the protein level of DNp63a (Figure 2b) .
To further investigate Pin1-p63 interaction, we generated H1299 cells stably expressing wild-type Pin1 (H1299:Pin1) or W34A mutant Pin1 [H1299:Pin1(W34A)], which cannot interact with p63. As shown in the bottom panel of Figure 2c , these two stable cell lines express comparable levels of exogenous wild-type or W34A mutant Pin1. After transfection with p63a or We next knocked down endogenous Pin1 using Pin1-specific siRNA. As shown in Figure 2e , siRNA-mediated knockdown of Pin1 in HEK293:DNp63a cells significantly downregulated DNp63a; Pin1 knockdown in H1299 cells also significantly reduced TAp63a and DNp63a, but not TAp63g (Supplementary Figure S2) . Given that the p63 and GFP expression plasmids used in our experiments were driven by the same CMV promoters, these data suggest that Pin1 likely upregulates TAp63a and DNp63a at post-transcriptional levels.
To examine whether Pin1 affects p63 protein stability, we measured the half-life of TAp63a protein in H1299 cells by means of cycloheximide (CHX) treatment. As shown in Figures 2f and g, Pin1 extended the half-life of TAp63a protein from 1.2 h to 2.2 h; by contrast, the stability of GFP was not significantly affected by Pin1 under similar settings.
Data from subsequent experiments with stable H1299 cell lines expressing wild-type or W34A mutant Pin1 showed that TAp63a has a longer half-life in H1299:Pin1 cells than in H1299:Pin1(W34A) cells (Supplementary Figure S3 ). With HEK293:DNp63a stable cells, we found that Pin1 extended the half-life of stably expressed DNp63a from about 4 h to approximately 7 h (Figures 2h and i) . Taken together, these data suggest that Pin1 binds to and stabilizes p63a proteins.
T538 is critical for Pin1-mediated TAp63a protein stabilization. Since Pin1 stabilizes p63a, but not p63g proteins, we speculated that some regions unique to p63a are required for Pin1 effect on p63a. As depicted in Figure 3a , p63a isoforms possess a unique C-terminal domain, containing six putative Pin1-binding motifs, which are absent in the alternatively spliced p63g isoforms; among these six Ser/ThrPro motifs, T 538 -Pro is adjacent to the P 540 PxY 543 motif, which was reported as the binding site for ubiquitin E3 ligase WWP1. 12 To identify which site is critical for Pin1-mediated stabilization of TAp63a, several single point mutations of TAp63a, including S463A, T491A, T538A, and T619A, were constructed. Wild-type TAp63a or mutant derivatives were transiently co-transfected into H1299:Pin1 or H1299:Pin1(W34A) cells. As shown in Figure 3b , wild-type TAp63a was significantly upregulated by wild-type Pin1; T538A, but not other point mutations, abolished the Pin1-mediated upregulation of TAp63a.
To confirm the importance of T 538 in Pin1-mediated regulation of TAp63a, we examined the protein levels of TAp63a(T538A) in H1299 cells in which Pin1 was simultaneously knocked down with specific siRNA. As shown in Figure 3c , knockdown of Pin1 led to downregulation of wildtype TAp63a, but not TAp63a (T538A).
These data suggest that T 538 P, which is adjacent to a P 540 PxY 543 motif, is involved in Pin1-mediated regulation of TAp63a stabilization.
Pin1 inhibits WWP1-dependent degradation of p63a proteins. To investigate whether proteasome-dependent protein degradation is involved in Pin1-mediated upregulation of p63a proteins, we treated cells with a specific proteasome inhibitor MG132 or the vehicle control, DMSO. As shown in Figure 4a, (Figure 4b) . However, the transfection control GFP, which is not targeted for proteasomal degradation, 13 was not affected by MG132 treatment and Pin1 expression. These data suggest that Pin1 inhibits proteasome-mediated degradation of p63a proteins.
WWP1 has been reported to function as a ubiquitin E3 ligase that promotes proteasome-dependent degradation of p63a proteins. 12 Our above-mentioned data indicate that Thr 538 -Pro, which is adjacent to the WWP1 binding site (PPxY motif), is critical to Pin1-mediated regulation of p63a stability ( Figure 3 ). As shown in Figure 4c , overexpression of WWP1 led to a significant decrease in TAp63a, which was prevented by co-expression of wild-type Pin1, but not Pin1(W34A). Similarly, Pin1 also significantly inhibited WWP1-mediated downregulation of DNp63a ( Figure 4d ). As shown in Figure 4e , knockdown of WWP1 increased TAp63a, whereas knockdown of Pin1 led to decrease in TAp63a; simultaneous knockdown of WWP1 abolished the downregulation of TAp63a mediated by Pin1 knockdown. These data suggest that Pin1 is involved in WWP1-mediated degradation of p63a. Since we have shown that T538 is critical for Pin1-mediated TAp63a stabilization (Figures 3b and c) , we next investigated the effect of WWP1 on TAp63a(T538A) protein stability. As shown in Figure 4f , WWP1 also decreased protein levels of TAp63a(T538A), suggesting that T538A substitution does not affect WWP1-mediated proteasomal degradation; however, overexpression of Pin1 failed to rescue WWP1-mediated downregulation of TAp63a(T538A), though T538A mutation abolished Pin1-mediated stabilization of wild-type TAp63a (Figures 3b and c) , suggesting that this substitution removes the binding of Pin1, but not of WWP1, to this region. Further study demonstrated that Pin1 impairs TAp63a-WWP1 but not TAp63a(T538A)-WWP1 interaction: as shown in Figure 4g , though the amount of immunoprecipitated wild-type MycTAp63a from H1299:Pin1 was much higher than that from H1299:Pin1(W34A), the amount of co-immunoprecipitated WWP1 was significantly lower than that from H1299:Pin1 (W34A); at the same time, immunoprecipitation with Myc antibody yielded similar amounts of either Myc-TAp63a(T538A) or WWP1 from H1299:Pin1 and H1299:Pin1(W34A).
These data suggest that Pin1 protects TAp63a from degradation via binding to its phospho-Thr 538 -Pro peptidyl-prolyl bonds and impairing the binding of WWP1 to the P 540 PxY 543 motif of TAp63a; T538A mutation in TAp63a abolishes the action of Pin1 on this site and it makes TAp63a(T538A) proteins vulnerable to WWP1-mediated degradation.
Pin1 enhances TAp63a-mediated transcription and apoptosis. To investigate whether the Pin1-mediated upregulation of TAp63a can stimulate transcription of its target genes, luciferase reporter assays were performed. Our results demonstrate that TAp63a upregulated the Bax-luc reporter activities (Figure 5a ), which was further enhanced by Pin1 (Figure 5b ) in a dose-dependent manner. In addition, TAp63a stimulated the expression of endogenous Puma, which was further enhanced by Pin1 (Figures 5c and d) . These results suggest that Pin1 has a positive role in regulating expression of downstream target genes of TAp63a, consistent with the results from a previous report. 8 To examine the effect of Pin1 on TAp63a-mediated apoptosis, H1299 cells co-transfected with TAp63a and/or Pin1 were subjected to immunoblotting or flow cytometry (FCM) analysis. The immunoblotting results showed that TAp63a induced the cleavage of PARP1, which is a hallmark of apoptosis; wild-type Pin1, but not Pin1(W34A), further increases TAp63a-induced PARP1 cleavage (Figure 5e ). FCM analysis further confirmed that wild-type Pin1, but not Pin1(W34A), promoted TAp63a-induced apoptosis (Figure 5f and Supplementary Figure S4) .
Ablation of Pin1 decreases expression of DNp63a, leading to inhibition of cell proliferation. Our abovementioned results demonstrated that, like TAp63a, DNp63a is also stabilized by Pin1 (Figures 2d, e, h, and 4d) . To investigate whether the Pin1 effect on DNp63a regulates cell proliferation and tumorigenesis, we established stable FaDu cells with knockdown of Pin1 (shPin1), simultaneous knockdown of both Pin1 and WWP1 (shPin1/shWWP1), or overexpression of DNp63a in Pin1-knockdown cells (shPin1/DNp63a). As shown in Figure 6a , knockdown of Pin1 in FaDu cells decreased DNp63a (lane 2 versus lane 1), which was rescued by simultaneous knockdown of WWP1 (lane 3 versus lane 2). Notably, shPin1/DNp63a cells did not yield much higher protein levels of DNp63a than control cells (Figure 6a, lane 4 versus lane 1) . This might be because Pin1 knockdown made both endogenous and exogenous DNp63a vulnerable to WWP1-mediated proteasomal degradation. Importantly, Pin1 knockdown led to significant decrease in cell proliferation, as shown by cell doubling time (Figure 6b ) as well as FCM analysis (Figures 6c and d) ; simultaneous knockdown of WWP1 largely rescued proliferation defect induced by knockdown of Pin1 (Figures 6b-d) . Furthermore, ectopic expression of DNp63a similar to knockdown of WWP1, was able to dramatically rescue inhibition of proliferation induced by Pin1 knockdown (Figures 6b-d) . These data suggest that Pin1-mediated modulation of DNp63a has an important role in cell proliferation.
Pin1-mediated stabilization of DNp63a has important roles in tumorigenesis. To investigate whether Pin1-mediated stabilization of DNp63a affects cell proliferation in vivo, we monitored tumor formation derived from FaDu cells in nude mice. The results showed that control FaDu cells can develop observable tumors, while ablation of Pin1 (FaDu:shPin1) led to dramatically reduced tumor formation (Figures 7a-c) . Importantly, simultaneous knockdown of both Pin1 and WWP1 (FaDu:shPin1/shWWP1) led to tumor formation much faster than FaDu:shPin1, although slower than controls (Figures 7a-c) . In addition, ectopic expression of DNp63a could also rescue the tumor growth defect resulted from Pin1 knockdown (Figures 7a-c) . These data suggest that Pin1 is critical for tumor formation in vivo, at least in part, through the WWP1-DNp63a pathway.
It has been shown that DNp63a is overexpressed in approximately 60% of oral squamous cell carcinoma (OSCC).
14 To investigate whether Pin1-DNp63a pathway has a clinical relevance, we examined the protein expression by immunoblotting with OSCC tumor tissues and paracancerous normal controls. As shown in Figure 7d and Supplementary Figure S5 , compared with their paracancerous normal controls (indicated as the horizontal line), protein levels of DNp63a and Pin1 were simultaneously elevated in 5 (1#, 3#, 6#, 8#, 12#) out of 12 OSCC patients. These data suggest that overexpression of Pin1 may have a role in stabilizing DNp63a in OSCC cells, that may contribute, in part, to the etiology of tumor development. Discussion p63 has been reported to have important roles in cell survival, proliferation, tumorigenesis, and development. 2, 15 Even though accumulating evidence indicates that posttranslational regulation of p63 is important in control of p63 activity, how p63 protein stability is regulated remains still largely unclear. In this study, we show that peptidyl-prolyl isomerase Pin1 is an important regulator of p63. We found that Pin1 directly binds to p63 and disrupts p63a-WWP1 interaction, resulting in p63a protein stabilization. In addition, we show that Pin1 enhances TAp63a-mediated apoptosis and promotes DNp63a-mediated putative Pin1-binding sites in the unique C-terminal regions of a isoforms (as depicted in Figure 3a) . Although the physical interaction between p63 and Pin1 was previously reported, the underlying mechanism and biological effects of Pin1-p63 direct interaction remain unclear. 8 Our data show that Pin1 interacts with p63 proteins, including TAa, DNa, TAg and DNg isoforms. However, Pin1 specially stabilizes a isoforms, but not g isoforms, indicating that these six Pin1-binding sites in the C-terminal region may have critical roles for protein Figure 5 Pin1 enhances TAp63a-mediated transcription and cell apoptosis. (a) TAp63a upregulates the expression of Bax-luc reporter in a dose-dependent manner. H1299 cells were co-transfected with 500 ng of Bax-luc reporter, 50 ng pCMV-Renilla reporter and increasing amounts of TAp63a expression plasmid (0, 20, 50, and 100 ng). Twenty-four hours post-transfection, the cells were lysed and Bax-luc and Renilla activities were measured. Immunoblotting analysis was performed to detect the expression of TAp63a. The Bax-Luc activity was normalized to Renilla activity and presented as fold activation with standard deviation (n ¼ 3). (b) Pin1 upregulates TAp63a-mediated Bax-luc expression in a dose-dependent manner. H1299 cells were co-transfected with 500 ng of Bax-luc reporter, 50 ng pCMV-Renilla reporter, 20 ng TAp63a expression plasmid and an increasing amount of pcDNA3.1-HA-Pin1 (0, 100, 200, and 5 ng). Twenty-four hours post-transfection, luciferase and Renilla activities were measured. The Bax-Luc activity was normalized to Renilla activity and presented as fold activation with standard deviation (n ¼ 3). Immunoblotting analysis was performed to detect the expression of TAp63a and Pin1. (c) Pin1 upregulates TAp63a-mediated expression of endogenous Puma. H1299:Pin1 or H1299:Pin1(W34A) cells were transfected with TAp63a or its vector control (200 ng). Forty-eight hours post-transfection, cells were lysed and subjected to immunoblotting analysis. The intensities of Puma bands were normalized with Actin. (d) Pin1 upregulates TAp63a and endogenous Puma in a dose-dependent manner. H1299 cells were transfected with fixed dose of TAp63a plasmid (100 ng), together with an increasing amount of pcDNA3.1-HA-Pin1 (0, 200, 500 and 1000 ng). Forty-eight hours post-transfection, the cells were lysed and subjected to immunoblotting analysis with indicated antibodies. The intensities of Puma bands were normalized with Actin. (e) and (f) Pin1 augments TAp63a-induced cell apoptosis. TAp63a (400 ng) was co-transfected with HA-Pin1 or HA-Pin1(W34A) (1600 ng) into H1299 cells in a 6-well plate. Twenty-four hours after transfection, cells were trypsinized and subjected to immunoblotting analysis (e) or flow cytometry analysis of apoptosis (f and Supplementary Figure S4) Pin1 stabilizes p63a proteins C Li et al stability of p63a isoforms. Although b isoforms have not been investigated in this work, we speculate that TAp63b and DNp63b can also be stabilized by Pin1, since they also contain the same TPPPxY sequence with p63a isoforms.
We further identified that T 538 in TAp63a is critical for Pin1-mediated stabilization of p63a isoforms. Notably, T 538 is adjacent to the WWP1 binding site (P 540 PxY 543 ), and WWP1 has been reported to target its substrate proteins, including p63a, for proteasome-dependent degradation. 12 Our data indicate that Pin1 inhibits the binding of WWP1 to p63a, likely because the isomerization resulted from the Pin1-p63 interaction affects the cyclization of the region encompassing PPxY motif of p63, which is important for the binding of WW domain of E3 ligases. 16, 17 It is also possible that the binding of Pin1 to phospho-Thr 538 -Pro interferes with WWP1-p63a interaction, since both of them bind to p63 via their WW domains. 12 Notably, since the E3 ligase Itch also binds to the same PPxY motif, [16] [17] [18] it is plausible that Pin1 may also affect p63-Itch interaction. Moreover, it has been reported that DNp63a can also undergo a proteasomal degradation pathway coordinately mediated by MDM2 and Fbw7 in HaCaT and U2OS cells; 19 it has been also documented that Pin1 can negatively regulate Fbw7 in human colon cancers and some cell lines including HCT116 and HeLa. 20 Therefore, Pin1 may protect p63 proteins from proteasomal degradation mediated by MDM2/Fbw7. Our data suggest that Itch or MDM2/Fbw7 are unlikely to have major roles in Pin1-mediated p63a stabilization in our experiment system, since the decrease in p63a protein levels mediated by Pin1 knockdown is almost completely rescued by simultaneous knockdown of WWP1.
Though endogenous TAp63 proteins are barely detectable in somatic cells, 21 overexpression of TAp63 proteins promotes cell cycle arrest and apoptotic cell death via activating p53 pro-apoptotic targets, such as Puma, Bax and Noxa. [22] [23] [24] Animal studies reveal that TAp63 induces senescence and suppress tumorigenesis and metastasis in vivo. 25, 26 In oocytes, TAp63a is responsible for DNA damage-induced apoptosis, therefore functioning as a quality control factor in the female germline. 27, 28 Together, these studies indicate that TAp63 functions to promote apoptosis. In this study, we show that Pin1 enhances TAp63a protein stability, thereby stimulating TAp63a-mediated gene expression, including Puma, and leading to enhanced apoptosis.
In contrast to the tumor suppressor activity of TAp63, DNp63 proteins inhibit apoptosis and promote cell proliferation via antagonizing transcriptional activities of p53, TAp63 and TAp73 proteins. 2 In the present work, we show that Pin1 reduces tumorigenicity of FaDu cells in xenograft animal models, indicating that Pin1 possesses strong oncogenic activity. FaDu is a human squamous carcinoma cell line, which expresses predominantly DNp63a. Our data indicate that knockdown of Pin1 leads to significant decrease in DNp63a protein level. Restoration of DNp63a protein levels, either by simultaneous knockdown of WWP1 or ectopic expression of DNp63a, significantly confers the tumor formation potential of the FaDu cells, indicating that the Pin1-WWP1-DNp63a pathway has important role in tumor development. Consistent with this notion, analysis of clinical samples reveals positive correlation of Pin1 and DNp63a expression in human oral squamous cell carcinoma. Although the amplification and transcription of p63 gene may contribute to p63 protein abundance in squamous cell carcinoma, 29 Pin1 likely has some role in p63a stability, since both p63a and Pin1 proteins were readily detected in the clinical samples. Together, these studies suggest that Pin1-DNp63a pathway may be critical for development of human squamous carcinoma.
It was recently reported that Pin1 promotes mutant p53-dependent inhibition of the p63 function via potentiating the complex formed by Smad2, p63 and mutant p53 and downregulating p63 anti-metastatic target genes. 8 In this work, we demonstrate that Pin1 can stabilize both TAp63a and DNp63a proteins, which functions as either a tumor suppressor or an oncoprotein, respectively (as depicted in Figure 8 ). Accumulating evidence indicates that Pin1 may exhibit tumor suppressor activity by positively regulating p53 and TAp73. 9, 10, 11, 30 On the other hand, Pin1 is upregulated in human tumors and may promote tumorigenesis via activating oncoproteins such as mutant p53 or inactivating tumor suppressors such as Rb. 8, 20, [31] [32] [33] In a given cell, the net effect of Pin1 may depend on the ratio of tumor suppressors (such as TAp63a) to oncoproteins (such as DNp63a) regulated by Pin1. Given the fact that DNp63a is the predominant p63 isoform and is overexpressed in human squamous carcinoma, our study suggests that Pin1 functions as an oncoprotein via activating DNp63a which may have important roles in certain tumor formation.
Materials and Methods
Constructs and siRNAs. Constructs of p63, Pin1 and Bax-luc reporters were previously described. [34] [35] [36] The full-length human WWP1 cDNA was cloned into pCMV (Clontech, New York City, NY, USA). Pin1 shRNA sequence (TGCTGTTGACAGTGAGCGAAGGCCGAGTGTACTACTTCAATAGTGAAGCC ACAGATGTATTGAAGTAGTACACTCGGCCTGTGCCTACTGCCTCGG) was cloned into pLKO.1 (Clontech). The construct of shWWP1 was purchased from Figure S5 ). Expression levels of DNp63a and Pin1 were normalized with actin, and ratio of either DNp63a or Pin1 in each paracancerous normal control was respectively set as 1.0 and indicated as the horizontal line Thermo Open Biosystem (Pittsburgh, PA, USA; target sequence: ATTGCTTATG AACGCGGCTTT). 37 Small interference RNAs (siRNAs) were synthesized by GenePharma (Shanghai, China). The target sequences are as below: siWWP1, GCAGAGAAATACTGTTTAT; 12 siPin1, GCCATTTGAAGACGCCTCG. 38 The specific siRNAs or scrambled controls were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
Cell culture, transfection and lentiviral infection. Cell culture and lentiviral infection were performed as described previously. 34 Transient transfection was performed with Lipofectamin2000 (Invitrogen), and total amounts of plasmid DNA were balanced with corresponding vectors. H1299:Pin1, H1299:Pin1(W34A) and HEK:DNp63a cells were screened with 2 mg/ml puromycin. To generate FaDu:shPin1, FaDu:shPin1/shWWP1 and FaDu:shPin1/DNp63a cells, FaDu cells were infected with shPin1, shWWP1 or DNp63a lentiviral particles sequentially, and screened with 2 mg/ml puromycin.
For growth curve analysis, cells tranfected with indicated genes were trypsinized and reseeded into 12-well plate at a density of 10 000 cells per well in triplicate. In the following 3 days, cells were trypsinized and counted at indicated time points.
Pull-down, immunoprecipitation and immunoblotting analysis. GST-fused wild-type and mutant Pin1 proteins were expressed and subjected to pull-down assay as described previously. 35 In brief, H1299 cells were transfected with expression plasmids of different p63 isoforms for 24 h and then lysed in EBC150 buffer containing 10% glycerol. A total of 500 mg of total proteins were subjected to GST pull-down assay with GST alone. The pull-down products or input samples were separated by 10% SDS-PAGE. Immunoblotting analysis (IB) was performed using indicated specific antibodies.
Immunoprecipitation (IP) and immunoblotting (IB) analysis were performed as previously described. 11, 34 Antibodies used were specific for p63 (4A4 monoclonal antibody, Santa Cruz, Dallas, TX, USA, 1 : 200), myc (9E10 monoclonal antibody, Santa Cruz, 1 : 1000), Pin1 (rabbit polyclonal antibody, Cell Signaling, Danvers, MA, USA, 1 : 1000), actin (rabbit polyclonal antibody, Santa Cruz, 1 : 1000), HA (mouse monoclonal antibody, Millipore, Billerica, MA, USA, 1 : 500), WWP1 (rabbit monoclonal antibody, Epitomics, Burlingame, CA, USA, 1 : 3000), Puma (rabbit polyclonal antibody, Santa Cruz, 1 : 1000), and N-terminal cleaved PARP1 (rabbit polyclonal antibodies, Zenable, Chengdu, China, 1 : 8000).
Luciferase reporter, flow cytometry and protein stability assays. Luciferase reporter assay was performed with Dual-Luciferase Reporter (DLR) Assay System (Promega, Fitchburg, WI, USA) according to the manufacturer's instructions. Flow cytometry (FCM) and protein stability assay was performed as described previously. 34 Xenograft experiments. Male SCID mice in a BALB/C background, at an age of 8-10 weeks at the time of inoculation, were used to establish xenografts. Cells (2 Â 10 6 /0.1 ml) were subcutaneously inoculated into the right flank of each nude mice. The volumes of xenograft were measured 15, 20, 22, and 24 days after inoculation. The tumor volumes were calculated according to the formula:volume ¼ length Â width 2 . The xenografts were dissected and weights were measured 24 days after inoculation.
Human oral squamous cell carcinoma samples. Human specimens of oral squamous cell carcinoma and paracancerous tissues were dissected from patients at surgery. Tissues were stored in liquid nitrogen until processing. For immunoblotting analysis, the tissues were ground in liquid nitrogen and lysed with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-Cl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, plus 5 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, and protease inhibitors).
Quantification and statistical analysis. Intensities of protein bands were quantified with Image Lab (Bio-Rad, Berkeley, CA, USA) and relative intensities were normalized with actin. Data were shown as means±standard deviations (S.D.). P-values were calculated using the Student's t test.
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